Zoetis (ZTS)
Frequently Asked Questions About Zoetis (ZTS)
How does Zoetis contribute to animal welfare?
Zoetis contributes to animal welfare by developing effective and safe health products that enhance the quality of life for animals. The company's commitment to research and innovation helps address health challenges faced by livestock and pets, ensuring they receive proper care and treatment.
How does Zoetis engage in corporate social responsibility?
Zoetis invests in corporate social responsibility initiatives that focus on animal welfare, community engagement, and environmental sustainability. The company collaborates with organizations to promote education and awareness around animal health, responsible pet ownership, and food safety.
How does Zoetis prioritize employee engagement?
Zoetis prioritizes employee engagement by fostering a culture of collaboration, innovation, and diversity. The company focuses on providing professional development opportunities, comprehensive benefits, and a supportive work environment that allows employees to thrive and contribute meaningfully to animal health.
How does Zoetis support veterinary professionals?
Zoetis supports veterinary professionals by providing not only high-quality products but also educational resources, training, and tools designed to enhance veterinary practice. The company is committed to helping veterinarians stay informed about the latest advancements in animal health and treatment options.
How has Zoetis adapted to changing market demands?
Zoetis has adapted to changing market demands by diversifying its product offerings and investing in digital health solutions. The company closely monitors trends in animal health and adjusts its strategies to meet the needs of veterinary professionals and animal owners in various regions.
In which markets does Zoetis operate?
Zoetis operates in more than 100 countries worldwide, ensuring a comprehensive reach in both domestic and international markets. The company serves a broad range of sectors within animal health, focusing on countries with large agricultural markets and significant pet ownership.
What are some key recent developments for Zoetis?
Recent developments for Zoetis include continuous investments in research and development to innovate in areas like biologics and data solutions for animal health. The company has been focusing on expanding its portfolio and enhancing its digital offerings to better serve veterinarians and pet owners.
What are Zoetis' future growth strategies?
Zoetis' future growth strategies include expanding its global presence through acquisitions, enhancing its product portfolio with innovative technologies, and investing in digital solutions to improve customer engagement and service delivery. The company aims to leverage its research capabilities to tap into emerging markets effectively.
What is the significance of Zoetis being publicly traded?
Zoetis is publicly traded on the New York Stock Exchange under the ticker symbol ZTS. This status allows the company to raise capital from investors, which supports its research and development initiatives, as well as its expansion efforts in the animal health market.
What is the significance of Zoetis’ research and development?
Research and development are vital for Zoetis as they drive innovation and product creation. The company dedicates a substantial portion of its budget to R&D to advance animal health technologies, ensuring that it remains a leader in the marketplace with cutting-edge solutions.
What is Zoetis?
Zoetis is a global animal health company that specializes in the development, manufacture, and marketing of veterinary pharmaceuticals and vaccines. Founded in 2013, it is known for providing a wide range of products and services that support the health and well-being of animals across various species, including livestock and companion animals.
What is Zoetis’ approach to sustainability?
Zoetis emphasizes sustainability in its operations and product development, aiming to minimize environmental impact while enhancing animal health. The company advocates for responsible use of animal health products and invests in sustainable agricultural practices that enhance food production and animal husbandry.
What is Zoetis’ mission?
Zoetis’ mission is to empower veterinarians and the livestock industry to achieve better animal health. The company is dedicated to providing innovative solutions that enhance animal care and health management while supporting the development of sustainable agricultural practices.
What is Zoetis’ position on antibiotic stewardship?
Zoetis is committed to antibiotic stewardship and promotes the responsible use of antibiotics in animal health. The company collaborates with veterinarians and farmers to develop strategies that maintain animal health while minimizing antibiotic resistance through appropriate medication use.
What role does innovation play at Zoetis?
Innovation is central to Zoetis' strategy, driving the creation of new products and solutions to meet the evolving needs of animal health. The company invests significantly in research to improve existing products and develop new therapeutic and preventive measures for animals.
What types of products does Zoetis offer?
Zoetis offers a diverse portfolio of products that includes vaccines, antibiotics, anti-parasitics, and nutritional products for both livestock and pets. Additionally, the company develops diagnostic products and provides services that assist veterinarians in diagnosing and treating animal health conditions.
Where is Zoetis headquartered?
Zoetis is headquartered in Parsippany, New Jersey, USA. This central location allows the company to effectively manage its global operations and collaborate with partners and stakeholders in the animal health sector.
Who are some of Zoetis’ competitors?
Zoetis faces competition from other major animal health companies, including Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim. These companies also provide a variety of products and services for livestock and companion animals and are important players in the global animal health market.
Who founded Zoetis?
Zoetis was originally a part of Pfizer Animal Health, which was associated with Pfizer Inc., a major pharmaceutical company. Zoetis became a standalone company when it was spun off from Pfizer in February 2013. The spin-off marked the beginning of Zoetis as an independent entity focused solely on animal health.
What is the current price of Zoetis?
The current price of Zoetis is 152.64
When was Zoetis last traded?
The last trade of Zoetis was at 2:55 pm EDT on April 4th, 2025
What is the market capitalization of Zoetis?
The market capitalization of Zoetis is 72.34B
How many shares of Zoetis are outstanding?
Zoetis has 473.94M shares outstanding.